The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Bortezomib reinduction therapy to improve response rates in pediatric ALL in first relapse: A Children’s Oncology Group (COG) study (AALL07P1).
Terzah M. Horton
Research Funding - Millennium
Xiaomin Lu
No relevant relationships to disclose
Maureen Megan O'Brien
No relevant relationships to disclose
Michael J. Borowitz
No relevant relationships to disclose
Meenakshi Devidas
No relevant relationships to disclose
Elizabeth A. Raetz
No relevant relationships to disclose
Patrick Andrew Brown
No relevant relationships to disclose
Hui Zeng
No relevant relationships to disclose
Hao W. Zheng
No relevant relationships to disclose
Stephen Hunger
No relevant relationships to disclose
James Whitlock
No relevant relationships to disclose